Clinical trial
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
NCT00079105 · Newcastle-upon-Tyne Hospitals NHS Trust, Other · Completed
Key facts
| NCT number | NCT00079105 |
|---|---|
| Title | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years |
| Official title | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years; Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma |
| Lead sponsor | Newcastle-upon-Tyne Hospitals NHS Trust, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, cyclophosphamide, etoposide, mitoxantrone hydrochloride, prednisolone, procarbazine hydrochloride, vinblastine sulfate |
| Enrollment | 175 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Mar 9, 2004 |
| Last update posted | Mar 30, 2017 |
| Countries | Germany, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: